VAERS reports by lot

Merck HPV lot 1687293: VAERS reports

55 VAERS reports list lot 1687293 as a Merck HPV vaccine, received between 2021-04-16 and 2024-06-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
55
Reports
2%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1634%
General / Systemic (non-local)919%
Allergic / Anaphylactic613%
Injection-site / Local reaction613%
Dermatological (non-injection-site)49%
Cardiac / Cardiovascular24%
Gastrointestinal24%
Musculoskeletal12%
Reproductive / Menstrual12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan31
New York3
Pennsylvania3
Minnesota2
North Carolina2
Washington2
Texas1
Maryland1
Virginia1
Illinois1
Delaware1
California1

Reports by month received

2021-0431
2021-081
2021-093
2021-103
2021-112
2022-032
2022-042
2022-063
2022-071
2022-091
2022-102
2022-111
2023-051
2023-061
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.